Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

January 19, 2025

Study Completion Date

February 24, 2028

Conditions
COVID19Influenza VaccinationACE InhibitorsARBAntihistamine AllergyAmantadine
Interventions
DRUG

Antihistamine

No intervention is performed. We propose an observational study.

DRUG

Amantadine

No intervention is performed. We propose an observational study

DRUG

ACEI

No intervention is performed. We propose an observational study.

DRUG

ARB

No intervention is performed. We propose an observational study.

OTHER

Influenza vaccine and COVID

No intervention is performed. We propose an observational study.

Trial Locations (1)

08227

RECRUITING

Hospital de Terrassa, Terrassa

All Listed Sponsors
collaborator

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER

collaborator

Institut Català de la Salut

OTHER

lead

Consorci Sanitari de Terrassa

OTHER